Big data is the datasets that are so large and complex that conventional methods and hardware for collecting, sharing, and analysing them are impossible. Although big data has been associated with the fields such as supercomputers, big data is the key for healthcare industry, including pharmaceutical sector to adapt themselves in this technology era.
The rapid development in technologies has increased the capacity of health information to be collected and analysed. For example, the big data is applied in the electronic medical record (EMR) where the medical information about a patient is stored in a computer and can be accessed and shared by all healthcare providers who are taking care of the patient.
Big data can improve the patient’s safety on medication by assessing the risk and side effects of drugs accurately according to the population health statistics on medication. Besides, pharmaceutical companies can utilise the big data to work in collaboration with insurance companies and scientists where their newest findings regarding drugs can be shared. Most importantly, pharmacists can build a relationship with patients through social media platforms and digital apps with the concept of big data. The data flow links from patient follow-ups and R&D to electronic physician medical records to ensure the best healthcare services to be delivered.
From a long-term perspective, big data ensures the continuity of pharmaceutical industries in delivering medication services in future. Hence, it is a positive sign for Malaysia to make an effort in popularising the use of big data among the healthcare sector.
